Glaxosmithkline Pharmaceuticals has informed that the Company has received an Order dated 4th February 2025 for the period July 2017 to March 2018 from Additional Commissioner Adjudication, Delhi-North, raising a demand of Rs 2,19,72,072 in Delhi State. The relevant details to be is disclosed is as enclosed.
The above information is a part of company’s filings submitted to BSE.